Okore V C, Attama A A, Ofokansi K C, Esimone C O, Onuigbo E B
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, 410001, Enugu State, Nigeria.
Indian J Pharm Sci. 2011 May;73(3):323-8. doi: 10.4103/0250-474X.93515.
Span 20-based niosome was prepared by lipid film hydration technique and loaded with Newcastle disease vaccine. Three batches with Span 20, cholesterol and dicetyl phosphate in micro molar ratios of 10:10:1; 15:15:1 and 20:20:1 were prepared and evaluated for encapsulation efficiency using haemagglutination test. The morphology of the vesicles was studied by means of transmission electron microscopy. Particle size, zeta potential and polydispersity index were determined by photon correlation spectroscopy using a nanosizer. Adjuvanticity was assessed using haemagglutination inhibition test. The vesicles of Span 20-based niosomes were distinct, near spherical large unilamellar vesicles. The vesicles were of varied sizes (<1000 nm) with the entrapped Newcastle disease vaccine in the core of the vaccine. The zeta potential had a peak at -50 mV. The polydispersity index was 0.68. Haemagglutination inhibition test showed a 71% increment in immune response over that of the marketed La Sota(®) vaccine which had a 60% increment in immune response. The niosomal vaccine did not alter but rather enhanced the immunogenicity of the Newcastle disease vaccine.
采用脂质膜水化技术制备了基于司盘20的脂质体,并负载新城疫疫苗。制备了三批司盘20、胆固醇和十六烷基磷酸酯摩尔比分别为10:10:1、15:15:1和20:20:1的脂质体,并用血凝试验评估其包封效率。通过透射电子显微镜研究了囊泡的形态。使用纳米粒度仪通过光子相关光谱法测定粒径、zeta电位和多分散指数。使用血凝抑制试验评估佐剂性。基于司盘20的脂质体囊泡明显,为近球形的大单层囊泡。囊泡大小各异(<1000 nm),新城疫疫苗包封于囊泡核心。zeta电位在-50 mV处出现峰值。多分散指数为0.68。血凝抑制试验表明,与市售La Sota®疫苗相比,免疫反应提高了71%,而市售La Sota®疫苗的免疫反应提高了60%。脂质体疫苗未改变新城疫疫苗的免疫原性,反而增强了其免疫原性。